Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care
Recruiting now · Not applicable
Conditions studied: Postpartum Period
In brief
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postpartum nadir occurs 48-72 hours after delivery due to the initial redistribution of plasma volume. The aim of this study was to examine whether postpartum ultrasound examination precedes laboratory test results in the diagnosis of anemia due to blood loss after cesarean section.
Key facts
- Study ID
- NCT06963047
- Run by
- Holy Family Hospital, Nazareth, Israel
- People needed
- 276
- Starts
- 2025-05-08
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-06-16
Who can join
Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women who delivered by a cesarean section.
- Age over 18.
- Fluent in Hebrew or Arabic.
- Signed informed consent form.
You may not qualify if…
- Lack of consent or inability to provide informed consent.
- Inability to perform a post-surgical ultrasound, such as post-surgery hospitalization in the intensive care unit.
- Women with preoperative coagulation disorders.
- Women whose clinical condition requires a post-cesarean ultrasound examination.
Where it is running
- Holy family hospital — Nazareth, North, Israel (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.